Market Research Logo

United States Intravenous Immunoglobulin (IVIg) Market Report 2017

United States Intravenous Immunoglobulin (IVIg) Market Report 2017

This report studies the Intravenous Immunoglobulin (IVIg) market status and outlook of United States and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in United States and major regions, and splits the Intravenous Immunoglobulin (IVIg) market by product type and applications/end industries.

In the last several years, United States market of Intravenous Immunoglobulin (IVIg) developed rapidly, with an average growth rate of 5.26%. In 2016, United States revenue of Intravenous Immunoglobulin (IVIg) is nearly 2556 M USD; the actual consumption is about 15.6 million bottles.

The major players in United States Intravenous Immunoglobulin (IVIg) market include
Baxalta
Grifols
CSL
Octapharma
Kedrion
BPL

Geographically, this report is segmented into several key Regions, with consumption, revenue, market share and growth rate of Intravenous Immunoglobulin (IVIg) in these regions, from 2012 to 2022 (forecast), covering
Northeast
Midwest
West
South

On the basis of product, the Intravenous Immunoglobulin (IVIg) market is primarily split into
IVIG Liquid
IVIG Powder

On the basis on the end users/applications, this report covers
Immunodeficiency
Autoimmune Disease
Acute Infection


1 Intravenous Immunoglobulin (IVIg) Overview
1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg)
1.2 Classification of Intravenous Immunoglobulin (IVIg) by Product Category
1.2.1 United States Intravenous Immunoglobulin (IVIg) Sales Comparison by Types (2012-2022)
1.2.2 United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Types (Product Category) in 2016
1.2.3 IVIg Liquid
1.2.4 IVIg Powder
1.3 United States Intravenous Immunoglobulin (IVIg) Market by Applications/End Users
1.3.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share Comparison by Applications (2012-2022)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 United States Intravenous Immunoglobulin (IVIg) Market by Regions
1.4.1 United States Intravenous Immunoglobulin (IVIg) Market Size Comparison by Regions (2012-2022)
1.4.2 The West Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
1.4.3 Northeast Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
1.4.4 The South Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
1.4.5 The Midwest Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
1.5 United States Market Size (Sales and Revenue) of Intravenous Immunoglobulin (IVIg) (2012-2022)
1.5.1 United States Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2022)
1.5.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2022)
1.6 USA CIDP Analysis
1.6.1 USA CIDP Patients Population Analysis 2012-2016
1.6.2 USA CIDP Treatment Approach Analysis 2012-2016
2 United States Intravenous Immunoglobulin (IVIg) Market Competition by Players/Manufacturers
2.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share of Key Players/Manufacturers (2016 and 2017)
2.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Share by Players/Manufacturers (2016 and 2017)
2.3 United States Intravenous Immunoglobulin (IVIg) Average Price by Players/Manufacturers (2016 and 2017)
2.4 United States Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
2.4.1 United States Intravenous Immunoglobulin (IVIg) Market Concentration Rate
2.4.2 United States Intravenous Immunoglobulin (IVIg) Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Manufacturers Intravenous Immunoglobulin (IVIg) Headquarters, Established Date, Product Types
3 United States Intravenous Immunoglobulin (IVIg) Sales and Revenue by Regions (2012-2017)
3.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Regions (2012-2017)
3.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Regions (2012-2017)
3.3 United States Intravenous Immunoglobulin (IVIg) Price by Regions (2012-2017)
4 United States Intravenous Immunoglobulin (IVIg) Sales and Revenue by Type/ Product Category (2012-2017)
4.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type/ Product Category (2012-2017)
4.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2012-2017)
4.3 United States Intravenous Immunoglobulin (IVIg) Price by Type (2012-2017)
4.4 United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Type (2012-2017)
5 United States Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)
5.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Applications (2012-2017)
5.2 United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Applications (2012-2017)
5.3 Market Drivers and Opportunities
6 Analysis of Intravenous Immunoglobulin (IVIg) Industry Key Manufacturers
6.1 Baxalta
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Cost, Gross, and Revenue
6.2 Grifols
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Cost, Gross, and Revenue
6.3 CSL
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Sales, Price, Cost, Gross, and Revenue
6.4 Octapharma
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Sales, Price, Cost, Gross, and Revenue
6.5 Kedrion
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Sales, Price, Cost, Gross, and Revenue
6.6 BPL
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Sales, Price, Cost, Gross, and Revenue
7 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
7.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.1.3 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost Analysis
7.2.3 Other Costs Analysis
7.2.3.1 USA Cost of Electricity Analysis
7.2.3.2 USA Water Cost Analysis
7.2.4 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Intravenous Immunoglobulin (IVIg) Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 United States Intravenous Immunoglobulin (IVIg) Sales and Revenue Forecast (2017-2022)
11.2 United States Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2017-2022)
11.3 United States Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2017-2022)
11.4 United States Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Intravenous Immunoglobulin (IVIg)
Table Classification of Intravenous Immunoglobulin (IVIg)
Figure United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) and Growth Rate Comparison by Types (Product Category) (2012-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Types (Product Category) in 2016
Figure IVIg Liquid Product Picture
Figure IVIg Powder Product Picture
Table Applications of Intravenous Immunoglobulin (IVIg)
Figure United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Comparison by Applications (2012-2022)
Figure United States Sales Market Share of Intravenous Immunoglobulin (IVIg) by Applications in 2016
Figure Immunodeficiency Examples
Figure Autoimmune Disease Examples
Figure Acute Infection Examples
Figure United States Intravenous Immunoglobulin (IVIg) Market Size (M USD) Comparison by Regions (2012-2022)
Figure The West Intravenous Immunoglobulin (IVIg) Revenue (M USD) and Growth Rate (2012-2022)
Figure Northeast Intravenous Immunoglobulin (IVIg) Revenue (M USD) and Growth Rate (2012-2022)
Figure The South Intravenous Immunoglobulin (IVIg) Revenue (M USD) and Growth Rate (2012-2022)
Figure The Midwest Intravenous Immunoglobulin (IVIg) Revenue (M USD) and Growth Rate (2012-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) and Growth Rate (2012-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue (M USD) and Growth Rate (2012-2022)
Table USA Patient Population in CIDP 2012-2016
Table USA Diagnosed Patient Population in CIDP 2012-2016
Table USA Treated Patient Population in CIDP 2012-2016
Table USA CIDP Treatment Approach Analysis 2012-2016
Table United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Key Players/Manufacturers (2016 and 2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Players/Manufacturers (2016 and 2017)
Figure 2016 United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Players/Manufacturers
Figure 2017 United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Players/Manufacturers
Table United States Intravenous Immunoglobulin (IVIg) Revenue (M USD) by Players/Manufacturers (2016 and 2017)
Table United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Players/Manufacturers (2016 and 2017)
Figure 2016 United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Players/Manufacturers
Figure 2017 United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Players/Manufacturers
Table United States Market Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Players/Manufacturers (2016 and 2017)
Figure United States Market Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Players/Manufacturers in 2016
Figure 2016 United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Players/Manufacturers
Figure United States Intravenous Immunoglobulin (IVIg) Market Share of Top 3 Players/Manufacturers in 2016
Figure United States Intravenous Immunoglobulin (IVIg) Market Share of Top 5 Players/Manufacturers in 2016
Table Mergers & Acquisitions, Expansion
Table United States Players/Manufacturers Intravenous Immunoglobulin (IVIg) Headquarters and Established Date
Table United States Players/Manufacturers Intravenous Immunoglobulin (IVIg) Product Category
Table United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Regions (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions in 2016
Table United States Intravenous Immunoglobulin (IVIg) Revenue (M USD) and Market Share by Regions (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions in 2016
Table United States Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Regions (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2016
Table United States Intravenous Immunoglobulin (IVIg) Revenue (M USD) and Market Share by Type (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2012-2017)
Figure Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Type (2012-2017)
Figure Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Type in 2016
Table United States Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Types (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Type (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Applications (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Applications (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Applications (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Applications in 2016
Figure United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Applications (2012-2017)
Table Market Drivers and Opportunities
Table Baxalta Company Profile
Figure Intravenous Immunoglobulin (IVIg) Product Information of Baxalta
Table Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Baxalta (2016 and 2017)
Table Grifols Company Profile
Figure Intravenous Immunoglobulin (IVIg) Product Information of Grifols
Table Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Grifols (2016 and 2017)
Table CSL Company Profile
Figure Intravenous Immunoglobulin (IVIg) Product Information of CSL
Table Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of CSL (2016 and 2017)
Table Octapharma Company Profile
Figure Intravenous Immunoglobulin (IVIg) Product Information of Octapharma
Table Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Octapharma (2016 and 2017)
Table Kedrion Company Profile
Figure Intravenous Immunoglobulin (IVIg) Product Information of Kedrion
Table Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Kedrion (2016 and 2017)
Table BPL Company Profile
Figure Intravenous Immunoglobulin (IVIg) Product Information of BPL
Table Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of BPL (2016 and 2017)
Table Key Raw Materials of Intravenous Immunoglobulin (IVIg) with Suppliers and Pictures
Figure Diagram of Automated Plasma Collection Procedure
Table Key Suppliers of Raw Materials
Table Global Plasma Collection by Region 2011-2016 (MT)
Figure Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure USA Labor Cost Analysis 2012-2016
Figure Cost of Employing a Factory Worker
Table Average Price of Electricity to Ultimate Customers 2007-2016
Figure Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
Table Major Buyers of Intravenous Immunoglobulin (IVIg)
Figure Setting Pricing Policy
Table Distributors/Traders List
Figure Schematic Representation of on Immunoglobulin G Molecule
Table US Food and Drug Administration Approved Use of IVIg
Figure Global GDP Growth Rate for 2016
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2016-2017
Figure United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) and Growth Rate Forecast (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue (M USD) and Growth Rate Forecast (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) Trend Forecast (2017-2022)
Table United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Type (2017-2022)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type in 2022
Table United States Intravenous Immunoglobulin (IVIg) Revenue (M USD) Forecast by Type (2017-2022)
Table United States Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type in 2022
Table United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Application (2017-2022)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application in 2022
Table United States Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Regions (2017-2022)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Regions (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Regions (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Regions in 2022
Table United States Intravenous Immunoglobulin (IVIg) Revenue (M USD) Forecast by Regions (2017-2022)
Table United States Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Regions (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Regions (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report